ESR2 and cancer: Notably, IPA analysis identified 12 of the ERβ-interacting proteins as having roles in cancer progression and metastasis with 4 of these proteins having established roles in NSCLC, i.e., EEFIA, MYL12A, TUBB2A, VIM1 (Table 3).